Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
Top Cited Papers
- 8 April 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Nanotechnology
- Vol. 7 (6), 383-388
- https://doi.org/10.1038/nnano.2012.45
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood PerfusionCancer Research, 2012
- Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor PenetrationAngewandte Chemie, 2011
- Normalization of the Vasculature for Treatment of Cancer and Other DiseasesPhysiological Reviews, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Scaling rules for diffusive drug delivery in tumor and normal tissuesProceedings of the National Academy of Sciences of the United States of America, 2011
- A Nanoparticle Size Series for In Vivo Fluorescence ImagingAngewandte Chemie, 2010
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Targeting of drugs and nanoparticles to tumorsThe Journal of cell biology, 2010
- Why are tumour blood vessels abnormal and why is it important to know?British Journal of Cancer, 2009
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007